Carles Domenech is the Executive Chairman and Chief Executive Officer at Ability Pharmaceuticals, a biopharmaceutical company developing anti-cancer drugs with a unique mechanism of action. Carles also holds various advisory and leadership positions in organizations related to biotechnology and business development. With a background in biology and extensive experience in the field, Carles Domenech is a versatile professional in the biotech industry.
January, 2022 - present
September, 2019
September, 2009